The Bob Harrington Show - Episode 39: The uptake of clinical trial findings: Focus on OAT




The Bob Harrington Show show

Summary: Recent reports indicate that the Occluded Arteries Trial (OAT)—while continuing to stir debate—has made little impact on clinical practice among US physicians. What explains this situation? Dr David Kandzari joins the show to take a broad look at the design, implementation, and uptake of clinical trials, with focus on strategy bias, how to follow evidence-based medicine, and why physicians are quick to act on certain trial results (but not others).